首页 > 最新文献

Gynecologic and Obstetric Investigation最新文献

英文 中文
Pain Level and Analgesic Requirements in Patients Who Underwent Vaginal Pelvic Floor Surgery following General or Spinal Anesthesia. 全身麻醉或脊髓麻醉后阴道盆底手术患者的疼痛水平和镇痛需求。
IF 2 4区 医学 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2025-01-01 Epub Date: 2024-12-02 DOI: 10.1159/000541962
Zehava Yohay, Yair Binyamin, Alla Saban, Adi Y Weintraub, Nurit Cohen, Neriya Zion Yohay, Michael Dubilet

Objective: This retrospective cohort study aimed to investigate postoperative pain levels and analgesic drug requirements in women who underwent general anesthesia (GA) or spinal anesthesia (SA) during vaginal pelvic floor surgeries.

Design: This was a retrospective cohort study.

Participants/materials, setting, methods: Women aged 18 or above who underwent vaginal pelvic floor surgery between 2019 and 2021 were included in the study. Univariate and multivariate analyses were performed separately for vaginal wall repair and stress urinary incontinence surgery.

Results: During the study period, 101 women underwent surgery under SA, and 99 women underwent surgery under GA. Intravenous analgesia administration rates were significantly lower under SA for both vaginal wall repair (20.2% vs. 38.9%, p = 0.017) and mid-urethral sling placement (20.2% vs. 37.8%, p = 0.007). Multivariate analysis revealed that intravenous analgesia requirement was significantly lower in the SA group than in the GA group after controlling for patient's age, concurrent hysterectomy, and mesh placement for vaginal wall repair (aOR = 0.33, p = 0.008) and mid-urethral sling placement (aOR = 0.37, p = 0.004).

Limitations: This is a retrospective study, thus the choice of anesthesia may be biased.

Conclusion: SA is associated with less postoperative pain and intravenous analgesia requirement in women who undergo vaginal pelvic floor surgeries. However, further research is needed to determine the preferred anesthesia method for specific types of pelvic floor surgeries.

目的:本回顾性队列研究旨在调查阴道盆底手术中接受GA或SA的女性术后疼痛水平和镇痛药物需求。设计:回顾性队列研究。参与者/材料、环境、方法:在2019年至2021年期间接受阴道盆底手术的18岁或以上女性纳入研究。对阴道壁修复和压力性尿失禁手术分别进行单因素和多因素分析。结果:在研究期间,101例女性在SA下手术,99例女性在GA下手术。阴道壁修复(20.2% vs. 38.9%, P=0.017)和尿道中悬吊带放置(20.2% vs. 37.8%, P= 0.007)在SA下静脉镇痛给药率均显著低于阴道壁修复(20.2% vs. 38.9%, P=0.017)。多因素分析显示,在控制患者年龄、同时切除子宫、放置阴道壁补片(aOR= 0.33, p=0.008)和放置尿道中吊带(aOR= 0.37, p=0.004)后,SA组静脉镇痛需求显著低于GA组。局限性:这是一项回顾性研究,因此麻醉的选择可能有偏倚。结论:SA与接受阴道盆底手术的妇女术后疼痛和静脉镇痛需求减少有关。然而,需要进一步的研究来确定特定类型盆底手术的首选麻醉方法。关键词:全身麻醉;脊髓麻醉,镇痛,盆底手术,盆腔器官脱垂,压力性尿失禁,eras。摘要:脊柱麻醉下阴道盆底手术术后疼痛和静脉镇痛需求较少。
{"title":"Pain Level and Analgesic Requirements in Patients Who Underwent Vaginal Pelvic Floor Surgery following General or Spinal Anesthesia.","authors":"Zehava Yohay, Yair Binyamin, Alla Saban, Adi Y Weintraub, Nurit Cohen, Neriya Zion Yohay, Michael Dubilet","doi":"10.1159/000541962","DOIUrl":"10.1159/000541962","url":null,"abstract":"<p><strong>Objective: </strong>This retrospective cohort study aimed to investigate postoperative pain levels and analgesic drug requirements in women who underwent general anesthesia (GA) or spinal anesthesia (SA) during vaginal pelvic floor surgeries.</p><p><strong>Design: </strong>This was a retrospective cohort study.</p><p><strong>Participants/materials, setting, methods: </strong>Women aged 18 or above who underwent vaginal pelvic floor surgery between 2019 and 2021 were included in the study. Univariate and multivariate analyses were performed separately for vaginal wall repair and stress urinary incontinence surgery.</p><p><strong>Results: </strong>During the study period, 101 women underwent surgery under SA, and 99 women underwent surgery under GA. Intravenous analgesia administration rates were significantly lower under SA for both vaginal wall repair (20.2% vs. 38.9%, p = 0.017) and mid-urethral sling placement (20.2% vs. 37.8%, p = 0.007). Multivariate analysis revealed that intravenous analgesia requirement was significantly lower in the SA group than in the GA group after controlling for patient's age, concurrent hysterectomy, and mesh placement for vaginal wall repair (aOR = 0.33, p = 0.008) and mid-urethral sling placement (aOR = 0.37, p = 0.004).</p><p><strong>Limitations: </strong>This is a retrospective study, thus the choice of anesthesia may be biased.</p><p><strong>Conclusion: </strong>SA is associated with less postoperative pain and intravenous analgesia requirement in women who undergo vaginal pelvic floor surgeries. However, further research is needed to determine the preferred anesthesia method for specific types of pelvic floor surgeries.</p>","PeriodicalId":12952,"journal":{"name":"Gynecologic and Obstetric Investigation","volume":" ","pages":"234-240"},"PeriodicalIF":2.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142768472","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Utility of an Human Papillomavirus Genotype Assay for Cancer Screening in Self-Collected Urine and Vaginal Samples from Japanese Women. 日本妇女自取尿液/阴道样本中的 HPV 基因型检测法在癌症筛查中的实用性。
IF 2 4区 医学 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2025-01-01 Epub Date: 2024-10-07 DOI: 10.1159/000541641
Mika Mizuno, Masaki Kamio, Mika Sakihama, Shintaro Yanazume, Shinichi Togami, Tadao Kakizoe, Hiroaki Kobayashi
<p><strong>Objectives: </strong>The high incidence of invasive cervical cancer among those who have not undergone cancer screening is a serious problem. This study aimed to investigate the utility of human papillomavirus (HPV) test results from self-collected urine and vaginal samples as screening tools.</p><p><strong>Design: </strong>The study was conducted in two steps. First, the appropriate storage container, temperature, and time until urine HPV assay performance were verified. Second, the results of spot urine testing under those conditions and of gynecologist-collected cervical and self-collected vaginal samples were compared to verify the feasibility of using the BD Onclarity® HPV assay for individuals with abnormal cervical cytology.</p><p><strong>Participants/materials, setting, methods: </strong>The participants were 121 women with abnormal cervical cytology. Self-collected urine and vaginal samples, along with gynecologist-collected cervical samples, were tested for HPV using the BD Onclarity® HPV assay. The optimal conditions for urine sample storage were identified by comparing the HPV detection rates under various conditions.</p><p><strong>Results: </strong>Urine stored in a BD Probe Tec™ (QxUPT) for less than 72 h at room temperature was found to have the highest HPV positivity rate. Under these conditions, the detection rates of HPV in urine, cervical, and vaginal samples were examined. HPV type 16 was detected in 41.7% of the cervical samples, type 18 in 10%, and types 31 and 52 in 12.6% each. The concordance rate for HPV testing between clinician-collected cervical and urine samples was 63.9% (kappa: 0.34; 95% CI: 0.21-0.47), and that between clinician-collected cervical and self-collected vaginal samples was 77.8% (kappa: 0.68; 95% CI: 0.53-0.83), indicating good concordance. In a population with an HPV-related lesion/tumor prevalence of approximately 70%, the sensitivity of HPV testing was 82.7% for the cervix, 46.4% for urine, and 75.7% for vaginal samples.</p><p><strong>Limitations: </strong>The primary limitation is the lower detection rate of HPV in spot urine samples than in other sample types, indicating room for methodological improvement. The study's findings are based on a specific population, which may limit generalizability.</p><p><strong>Conclusions: </strong>We investigated the optimal self-collected urine-to-testing time and temperature. Self-collected vaginal and urine HPV tests show moderate-high concordance with clinician-collected cervical HPV tests, suggesting their potential utility for women who do not undergo regular cancer screening. However, the sensitivity was not high in spot urine. Therefore, further large-scale studies are needed to verify these findings and optimize testing methods to encourage broader participation in cancer screening programs.</p><p><strong>Objectives: </strong>The high incidence of invasive cervical cancer among those who have not undergone cancer screening is a serious problem
目的 在未接受癌症筛查的人群中,浸润性宫颈癌的发病率很高,这是一个严重的问题。本研究旨在探讨将自取尿液和阴道样本中的 HPV 检测结果作为筛查工具的实用性。设计 研究分两步进行。首先,验证适当的储存容器、温度和时间直至尿液 HPV 检测结果。其次,比较在这些条件下的尿液定点检测结果以及妇科医生采集的宫颈样本和自取的阴道样本,以验证对宫颈细胞学异常者使用 BD Onclarity® HPV 检测的可行性。参与者/材料、环境、方法 参与者为 121 名宫颈细胞学检查异常的女性。使用 BD Onclarity® HPV 检测法对自取的尿液和阴道样本以及妇科医生采集的宫颈样本进行 HPV 检测。通过比较不同条件下的 HPV 检测率,确定了尿液样本的最佳储存条件。结果发现,室温下在 BD Probe Tec™ (QxUPT) 中储存少于 72 小时的尿液 HPV 阳性率最高。在这些条件下,对尿液、宫颈和阴道样本中的 HPV 检测率进行了检测。在 41.7% 的宫颈样本中检测到了 HPV 16 型,10% 检测到了 18 型,31 型和 52 型各占 12.6%。临床医生采集的宫颈样本和尿液样本之间的 HPV 检测吻合率为 63.9%(kappa 0.34;95% CI:0.21-0.47),临床医生采集的宫颈样本和自我采集的阴道样本之间的吻合率为 77.8%(kappa 0.68;95% CI:0.53-0.83),表明吻合度良好。在HPV相关病变/肿瘤发病率约为70%的人群中,宫颈、尿液和阴道样本的HPV检测灵敏度分别为82.7%、46.4%和75.7%。局限性 主要的局限性是点滴尿液样本中 HPV 的检测率低于其他样本类型,这表明检测方法还有改进的余地。研究结果是基于特定人群得出的,这可能会限制研究结果的普遍性。结论 我们研究了自取尿液检测的最佳时间和温度。自取阴道和尿液的 HPV 检测与临床医生采集的宫颈 HPV 检测显示出中等-高度的一致性,这表明它们对未定期接受癌症筛查的妇女具有潜在的实用性。不过,定点尿液的灵敏度不高。因此,需要进一步的大规模研究来验证这些发现,并优化检测方法,以鼓励更多的人参与癌症筛查项目。
{"title":"The Utility of an Human Papillomavirus Genotype Assay for Cancer Screening in Self-Collected Urine and Vaginal Samples from Japanese Women.","authors":"Mika Mizuno, Masaki Kamio, Mika Sakihama, Shintaro Yanazume, Shinichi Togami, Tadao Kakizoe, Hiroaki Kobayashi","doi":"10.1159/000541641","DOIUrl":"10.1159/000541641","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Objectives: &lt;/strong&gt;The high incidence of invasive cervical cancer among those who have not undergone cancer screening is a serious problem. This study aimed to investigate the utility of human papillomavirus (HPV) test results from self-collected urine and vaginal samples as screening tools.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Design: &lt;/strong&gt;The study was conducted in two steps. First, the appropriate storage container, temperature, and time until urine HPV assay performance were verified. Second, the results of spot urine testing under those conditions and of gynecologist-collected cervical and self-collected vaginal samples were compared to verify the feasibility of using the BD Onclarity® HPV assay for individuals with abnormal cervical cytology.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Participants/materials, setting, methods: &lt;/strong&gt;The participants were 121 women with abnormal cervical cytology. Self-collected urine and vaginal samples, along with gynecologist-collected cervical samples, were tested for HPV using the BD Onclarity® HPV assay. The optimal conditions for urine sample storage were identified by comparing the HPV detection rates under various conditions.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;Urine stored in a BD Probe Tec™ (QxUPT) for less than 72 h at room temperature was found to have the highest HPV positivity rate. Under these conditions, the detection rates of HPV in urine, cervical, and vaginal samples were examined. HPV type 16 was detected in 41.7% of the cervical samples, type 18 in 10%, and types 31 and 52 in 12.6% each. The concordance rate for HPV testing between clinician-collected cervical and urine samples was 63.9% (kappa: 0.34; 95% CI: 0.21-0.47), and that between clinician-collected cervical and self-collected vaginal samples was 77.8% (kappa: 0.68; 95% CI: 0.53-0.83), indicating good concordance. In a population with an HPV-related lesion/tumor prevalence of approximately 70%, the sensitivity of HPV testing was 82.7% for the cervix, 46.4% for urine, and 75.7% for vaginal samples.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Limitations: &lt;/strong&gt;The primary limitation is the lower detection rate of HPV in spot urine samples than in other sample types, indicating room for methodological improvement. The study's findings are based on a specific population, which may limit generalizability.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusions: &lt;/strong&gt;We investigated the optimal self-collected urine-to-testing time and temperature. Self-collected vaginal and urine HPV tests show moderate-high concordance with clinician-collected cervical HPV tests, suggesting their potential utility for women who do not undergo regular cancer screening. However, the sensitivity was not high in spot urine. Therefore, further large-scale studies are needed to verify these findings and optimize testing methods to encourage broader participation in cancer screening programs.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Objectives: &lt;/strong&gt;The high incidence of invasive cervical cancer among those who have not undergone cancer screening is a serious problem","PeriodicalId":12952,"journal":{"name":"Gynecologic and Obstetric Investigation","volume":" ","pages":"143-152"},"PeriodicalIF":2.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11965806/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142390065","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Polycystic Ovary Syndrome, Endometriosis, and Venous Thromboembolism: A Population-Based Study. 多囊卵巢综合征、子宫内膜异位症与静脉血栓栓塞症:一项基于人群的研究。
IF 2.3 4区 医学 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2025-01-01 Epub Date: 2025-04-03 DOI: 10.1159/000545518
Steeve Provencher, Hormoz Nassiri Kigloo, Vicky Mai, Eva Suarthana, Togas Tulandi, Steeve Provencher

Background: There is a paucity of studies on the association between polycystic ovary syndrome (PCOS) and endometriosis and the occurrence of venous thromboembolism (VTE).

Objective: Our study aimed to evaluate the association between PCOS, endometriosis, deep vein thrombosis (DVT), and pulmonary embolism (PE).

Methods: This was a retrospective study of prospectively collected data using the Healthcare Cost and Utilization Project databases. We examined the association between PCOS and endometriosis with DVT and PE from a cohort of 12,814,970 female patients, aged 18-49 years, who were hospitalized between 2007 and 2014.

Results: We observed increasing trends, with a relative increase of 140% (from 0.27% to 0.65%) for PCOS, 16% (from 0.43% to 0.50%) for DVT, and 39% (from 0.23% to 0.32%) for PE, whereas we observed a decline by 34% for endometriosis (from 0.85% to 0.56%). The unadjusted analysis showed an association between PCOS and VTE, which remained significant after adjustment for sociodemographic characteristics and comorbidities (OR = 2.16; 95% CI: 2.00-2.33 and OR = 2.44; 95% CI: 2.23-2.67 for DVT and PE, respectively). The association between endometriosis and VTE was age-dependent, with an increased risk of VTE among women 18-24 years whereas this risk was decreased among those 35 years and older.

Conclusion: Our study indicates an association between PCOS and VTE and an age-dependent association between endometriosis and VTE.

背景:目前关于多囊卵巢综合征(PCOS)和子宫内膜异位症与静脉血栓栓塞(VTE)发生之间关系的研究较少。目的:探讨多囊卵巢综合征(PCOS)与子宫内膜异位症、深静脉血栓形成(DVT)和肺栓塞(PE)的关系。方法:这是一项回顾性研究,使用医疗成本和利用项目数据库前瞻性地收集数据。我们从2007年至2014年间住院的12814970名年龄在18岁至49岁的女性患者中研究了PCOS和子宫内膜异位症与DVT和PE之间的关系。结果:我们观察到增加趋势,PCOS相对增加140%(从0.27%到0.65%),DVT相对增加16%(从0.43%到0.50%),PE相对增加39%(从0.23%到0.32%),而子宫内膜异位症相对下降34%(从0.85%到0.56%)。未经调整的分析显示PCOS和VTE之间存在关联,在调整了社会人口学特征和合并症后,这种关联仍然显著(OR=2.16;95%CI 2.00-2.33和2.44;DVT和PE的95%CI分别为2.23-2.67)。子宫内膜异位症和静脉血栓栓塞之间的关系是年龄依赖性的,18-24岁的女性患静脉血栓栓塞的风险增加,而35岁及以上的女性患静脉血栓栓塞的风险降低。结论:我们的研究表明PCOS与VTE之间存在关联,子宫内膜异位症与VTE之间存在年龄依赖性关联。
{"title":"Polycystic Ovary Syndrome, Endometriosis, and Venous Thromboembolism: A Population-Based Study.","authors":"Steeve Provencher, Hormoz Nassiri Kigloo, Vicky Mai, Eva Suarthana, Togas Tulandi, Steeve Provencher","doi":"10.1159/000545518","DOIUrl":"10.1159/000545518","url":null,"abstract":"<p><strong>Background: </strong>There is a paucity of studies on the association between polycystic ovary syndrome (PCOS) and endometriosis and the occurrence of venous thromboembolism (VTE).</p><p><strong>Objective: </strong>Our study aimed to evaluate the association between PCOS, endometriosis, deep vein thrombosis (DVT), and pulmonary embolism (PE).</p><p><strong>Methods: </strong>This was a retrospective study of prospectively collected data using the Healthcare Cost and Utilization Project databases. We examined the association between PCOS and endometriosis with DVT and PE from a cohort of 12,814,970 female patients, aged 18-49 years, who were hospitalized between 2007 and 2014.</p><p><strong>Results: </strong>We observed increasing trends, with a relative increase of 140% (from 0.27% to 0.65%) for PCOS, 16% (from 0.43% to 0.50%) for DVT, and 39% (from 0.23% to 0.32%) for PE, whereas we observed a decline by 34% for endometriosis (from 0.85% to 0.56%). The unadjusted analysis showed an association between PCOS and VTE, which remained significant after adjustment for sociodemographic characteristics and comorbidities (OR = 2.16; 95% CI: 2.00-2.33 and OR = 2.44; 95% CI: 2.23-2.67 for DVT and PE, respectively). The association between endometriosis and VTE was age-dependent, with an increased risk of VTE among women 18-24 years whereas this risk was decreased among those 35 years and older.</p><p><strong>Conclusion: </strong>Our study indicates an association between PCOS and VTE and an age-dependent association between endometriosis and VTE.</p>","PeriodicalId":12952,"journal":{"name":"Gynecologic and Obstetric Investigation","volume":" ","pages":"603-610"},"PeriodicalIF":2.3,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143779835","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Outcomes Post-Laparoscopic Intervention for Accessory and Cavitated Uterine Masses: A Review and a Molecular Insight. 腹腔镜后干预辅助和空腔子宫肿块:综述和分子的见解。
IF 2.3 4区 医学 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2025-01-01 Epub Date: 2025-02-26 DOI: 10.1159/000543762
Mohamed A Bedaiwy, Ella Barrett-Chan, Karim Alomar, Esra Apos A Bukannan, Kristy Cho, Jessica A Pilsworth, C Blake Gilks, Paul Yong, David G Huntsman, Mohamed Bedaiwy

Background: Accessory and cavitated uterine masses (ACUM) are rare Mullerian anomalies, defined as an isolated accessory cavitated mass lined with endometrial epithelium.

Objectives: This article explores ACUM lesions from two aspects and integrates a case report of a successful laparoscopic-assisted intervention for ACUM in a 24-year-old woman with refractory dysmenorrhea with a review of current literature on laparoscopic surgical techniques. Unique to this case was the process of undergoing targeted genetic sequencing via the Find ITTM Panel Version 3.4 on the ACUM, looking for mutations in KRAS, PIK3CA, and FGFR2. A process that was inspired by recent reports that indicate that even normal endometrium can harbor cancer-associated mutations.

Methods: A comprehensive search of Ovid MEDLINE and Embase was performed. Studies were selected if they explored laparoscopic surgery's impact on ACUM patients' outcomes related to fertility, menorrhagia, or dysmenorrhea. Risk of bias assessment was performed using the JBI Critical Appraisal Checklist.

Outcome: From 160 articles identified, 25 full-text articles were analyzed with a total of 75 unique patients discussed. Dysmenorrhea was present in 100% of cases (n = 75/75), and laparoscopic resection improved patient symptoms in 84% (n = 63/75) of cases. The mass excised in the case was positive for somatic missense mutations in RET (R813W) and HRAS (G12S) genes, identified at low variant allele frequencies.

Conclusions and outlook: These results demonstrated that laparoscopic surgical approaches are effective and frequently the first surgical approach chosen for the treatment of ACUM, but that techniques to treat these conditions are not standardized. This case is the first to demonstrate mutations in ACUM, suggesting a potential role for cancer-associated somatic mutations in their genesis. Future developments in this area may include sending more of these samples for genetic analysis, improving our understanding of how these lesions are formed, while also working to standardize how they are removed.

背景:辅助空腔子宫肿块(ACUM)是一种罕见的缪勒氏异常,定义为孤立的伴子宫内膜上皮的辅助空腔肿块。目的:本文从两个方面探讨ACUM的病变,并结合一例24岁难治性痛经女性ACUM的腹腔镜辅助干预成功病例报告,回顾目前腹腔镜手术技术的文献。该病例的独特之处在于通过ACUM上的Find ITTM Panel Version 3.4进行靶向基因测序,寻找KRAS、PIK3CA和FGFR2的突变。这一过程受到最近报告的启发,该报告指出,即使是正常的子宫内膜也可能存在与癌症相关的突变。方法:综合检索Ovid MEDLINE和Embase。如果研究探讨腹腔镜手术对ACUM患者生育、月经过多或痛经相关结果的影响,则选择研究。使用JBI关键评估清单进行偏倚风险评估。结果:从160篇文章中,分析了25篇全文文章,共讨论了75名独特的患者。100%的病例(n=75/75)出现痛经,腹腔镜切除术改善了84% (n=63/75)病例的症状。该病例切除的肿块在RET (R813W)和HRAS (G12S)基因的体细胞错义突变中呈阳性,鉴定为低变异等位基因频率。结论和展望:这些结果表明腹腔镜手术入路是有效的,并且经常是治疗ACUM的首选手术入路,但治疗这些疾病的技术尚未标准化。该病例是首次证实ACUM突变的病例,表明与癌症相关的体细胞突变在其发生过程中可能起作用。该领域的未来发展可能包括发送更多的这些样本进行遗传分析,提高我们对这些病变如何形成的理解,同时也努力使它们的移除方式标准化。
{"title":"Outcomes Post-Laparoscopic Intervention for Accessory and Cavitated Uterine Masses: A Review and a Molecular Insight.","authors":"Mohamed A Bedaiwy, Ella Barrett-Chan, Karim Alomar, Esra Apos A Bukannan, Kristy Cho, Jessica A Pilsworth, C Blake Gilks, Paul Yong, David G Huntsman, Mohamed Bedaiwy","doi":"10.1159/000543762","DOIUrl":"10.1159/000543762","url":null,"abstract":"<p><strong>Background: </strong>Accessory and cavitated uterine masses (ACUM) are rare Mullerian anomalies, defined as an isolated accessory cavitated mass lined with endometrial epithelium.</p><p><strong>Objectives: </strong>This article explores ACUM lesions from two aspects and integrates a case report of a successful laparoscopic-assisted intervention for ACUM in a 24-year-old woman with refractory dysmenorrhea with a review of current literature on laparoscopic surgical techniques. Unique to this case was the process of undergoing targeted genetic sequencing via the Find ITTM Panel Version 3.4 on the ACUM, looking for mutations in KRAS, PIK3CA, and FGFR2. A process that was inspired by recent reports that indicate that even normal endometrium can harbor cancer-associated mutations.</p><p><strong>Methods: </strong>A comprehensive search of Ovid MEDLINE and Embase was performed. Studies were selected if they explored laparoscopic surgery's impact on ACUM patients' outcomes related to fertility, menorrhagia, or dysmenorrhea. Risk of bias assessment was performed using the JBI Critical Appraisal Checklist.</p><p><strong>Outcome: </strong>From 160 articles identified, 25 full-text articles were analyzed with a total of 75 unique patients discussed. Dysmenorrhea was present in 100% of cases (n = 75/75), and laparoscopic resection improved patient symptoms in 84% (n = 63/75) of cases. The mass excised in the case was positive for somatic missense mutations in RET (R813W) and HRAS (G12S) genes, identified at low variant allele frequencies.</p><p><strong>Conclusions and outlook: </strong>These results demonstrated that laparoscopic surgical approaches are effective and frequently the first surgical approach chosen for the treatment of ACUM, but that techniques to treat these conditions are not standardized. This case is the first to demonstrate mutations in ACUM, suggesting a potential role for cancer-associated somatic mutations in their genesis. Future developments in this area may include sending more of these samples for genetic analysis, improving our understanding of how these lesions are formed, while also working to standardize how they are removed.</p>","PeriodicalId":12952,"journal":{"name":"Gynecologic and Obstetric Investigation","volume":" ","pages":"398-408"},"PeriodicalIF":2.3,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143515443","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
METTL14 Promotes Proliferation, Migration, and Invasion in Endometriotic Stromal Cell Growth by Activating the ZEB1/MEK/ERK Pathway. METTL14 通过激活 ZEB1/MEK/ERK 通路,促进子宫内膜异位基质细胞的增殖、迁移和侵袭。
IF 2 4区 医学 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2025-01-01 Epub Date: 2024-07-17 DOI: 10.1159/000539656
Xuan Lv, Fang Li

Objective: The aim of this study was to explore the mechanism of methyltransferase-like 14 (METTL14) on human endometriotic stromal cell (ESC; HEM15A) proliferation, migration, and invasion to provide novel therapy for endometriosis (EMs).

Design: Normal human endometrial stromal cells (HESCs) and HEM15A cells were selected. Corresponding controlled experiments were performed to analyze whether overexpression of METTL14, N6-methyladenosine (m6A) methylated ZEB1 mRNA, upregulation of ZEB1, and activating the mitogen-activated protein kinase kinase (MEK)/extracellular signal-regulated kinase (ERK) can affect the proliferation, migration, and invasion of HEM15A cells. Materials, Setting, and Methods: HEM15A and HESCs were cultured in vitro. HEM15A cells were treated with oe-METTL14 and oe-zinc finger E-box-binding protein 1 (ZEB1) plasmids, 3-deazaadenosine (3-DAA) and the MEK/ERK pathway inhibitor isoprenaline (ISO). After identifying HEM15A and HESCs, METTL14, ZEB1, p-ERK1/2/ERK1/2, and p-MEK/MEK levels, and cell proliferation, migration, and invasion were assessed. The modification sites of ZEB1 and m6A were predicted using SRAMP database, with an m6A modification level assessed by MeRIP. The binding of YT521-B homology domain 2 (YTHDF2) to ZEB1 messenger RNA (mRNA), and ZEB1 stability and mRNA level were tested.

Results: Compared with HESCs, METTL14 level in HEM15A was significantly reduced. METTL14 overexpression in HEM15A prominently increased its proliferation, migration, and invasion. METTL14 overexpression notably elevated m6A-methylated ZEB1 mRNA level and reduced the stability and expression of ZEB1 mRNA. Further m6A modification inhibition increased ZEB1 mRNA stability and mRNA and protein levels and decreased ZEB1 m6A modification level. ZEB1 upregulation partially reversed METTL14 overexpression-inhibited HEM15A proliferation, migration, and invasion. METTL14 inhibited the MEK/ERK signaling activation by regulating ZEB1, and the MEK/ERK signaling activation partly averted METTL14-suppressed proliferation, migration, and invasion.

Limitations: The effects of METTL14 on other growth aspects of HEM15A cells and the relation between ZEB1 and m6A require further investigation.

Conclusions: METTL14 lowered ZEB1 expression by regulating ZEB1 m6A modification levels, thereby inhibiting the activation of the MEK/ERK pathway and ESC proliferation, migration, and invasion.

目的:子宫内膜异位症(EMs)常见于生育期妇女。方法:体外培养 HEM15A 和人子宫内膜基质细胞(HESCs)。用oe-METTL14和oe-锌指E-盒结合蛋白1(ZEB1)质粒、N6-甲基腺苷(m6A)抑制剂3-脱氮腺苷(3-DAA)和丝裂原活化蛋白激酶(MEK)/细胞外信号调节激酶(ERK)通路抑制剂异丙肾上腺素(ISO)处理HEM15A细胞。在鉴定 HEM15A 和 HESCs 后,评估了 METTL14、ZEB1、p-ERK1/2/ERK1/2 和 p-MEK/MEK 水平以及细胞增殖、迁移和侵袭情况。利用SRAMP数据库预测了ZEB1和m6A的修饰位点,并通过MeRIP评估了m6A的修饰水平。检测了YT521-B同源结构域2(YTHDF2)与ZEB1信使RNA(mRNA)的结合、ZEB1的稳定性和mRNA水平:结果:与HESCs相比,HEM15A中的METTL14水平明显降低。METTL14在HEM15A中的过表达显著增加了其增殖、迁移和侵袭能力。METTL14 的过表达会明显降低 m6A 甲基化的 ZEB1 mRNA 水平,并降低 ZEB1 mRNA 的稳定性和表达量。进一步的 m6A 修饰抑制增加了 ZEB1 mRNA 的稳定性以及 mRNA 和蛋白质水平,并降低了 ZEB1 m6A 修饰水平。ZEB1 的上调部分逆转了 METTL14 过表达抑制的 HEM15A 增殖、迁移和侵袭。METTL14通过调节ZEB1抑制了MEK/ERK信号的激活,而MEK/ERK信号的激活部分避免了METTL14抑制的增殖、迁移和侵袭:结论:METTL14通过调节ZEB1 m6A修饰水平降低了ZEB1的表达,从而抑制了MEK/ERK通路的激活,抑制了ESC的增殖、迁移和侵袭。
{"title":"METTL14 Promotes Proliferation, Migration, and Invasion in Endometriotic Stromal Cell Growth by Activating the ZEB1/MEK/ERK Pathway.","authors":"Xuan Lv, Fang Li","doi":"10.1159/000539656","DOIUrl":"10.1159/000539656","url":null,"abstract":"<p><strong>Objective: </strong>The aim of this study was to explore the mechanism of methyltransferase-like 14 (METTL14) on human endometriotic stromal cell (ESC; HEM15A) proliferation, migration, and invasion to provide novel therapy for endometriosis (EMs).</p><p><strong>Design: </strong>Normal human endometrial stromal cells (HESCs) and HEM15A cells were selected. Corresponding controlled experiments were performed to analyze whether overexpression of METTL14, N6-methyladenosine (m6A) methylated ZEB1 mRNA, upregulation of ZEB1, and activating the mitogen-activated protein kinase kinase (MEK)/extracellular signal-regulated kinase (ERK) can affect the proliferation, migration, and invasion of HEM15A cells. Materials, Setting, and Methods: HEM15A and HESCs were cultured in vitro. HEM15A cells were treated with oe-METTL14 and oe-zinc finger E-box-binding protein 1 (ZEB1) plasmids, 3-deazaadenosine (3-DAA) and the MEK/ERK pathway inhibitor isoprenaline (ISO). After identifying HEM15A and HESCs, METTL14, ZEB1, p-ERK1/2/ERK1/2, and p-MEK/MEK levels, and cell proliferation, migration, and invasion were assessed. The modification sites of ZEB1 and m6A were predicted using SRAMP database, with an m6A modification level assessed by MeRIP. The binding of YT521-B homology domain 2 (YTHDF2) to ZEB1 messenger RNA (mRNA), and ZEB1 stability and mRNA level were tested.</p><p><strong>Results: </strong>Compared with HESCs, METTL14 level in HEM15A was significantly reduced. METTL14 overexpression in HEM15A prominently increased its proliferation, migration, and invasion. METTL14 overexpression notably elevated m6A-methylated ZEB1 mRNA level and reduced the stability and expression of ZEB1 mRNA. Further m6A modification inhibition increased ZEB1 mRNA stability and mRNA and protein levels and decreased ZEB1 m6A modification level. ZEB1 upregulation partially reversed METTL14 overexpression-inhibited HEM15A proliferation, migration, and invasion. METTL14 inhibited the MEK/ERK signaling activation by regulating ZEB1, and the MEK/ERK signaling activation partly averted METTL14-suppressed proliferation, migration, and invasion.</p><p><strong>Limitations: </strong>The effects of METTL14 on other growth aspects of HEM15A cells and the relation between ZEB1 and m6A require further investigation.</p><p><strong>Conclusions: </strong>METTL14 lowered ZEB1 expression by regulating ZEB1 m6A modification levels, thereby inhibiting the activation of the MEK/ERK pathway and ESC proliferation, migration, and invasion.</p>","PeriodicalId":12952,"journal":{"name":"Gynecologic and Obstetric Investigation","volume":" ","pages":"42-54"},"PeriodicalIF":2.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141456336","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effectiveness of Mechanical Bowel Preparation before Robot-Assisted Laparoscopic Gynecologic Surgery: A Randomized, Single-Blind, Controlled Trial. 机器人辅助腹腔镜妇科手术前机械肠道准备的效果:随机、单盲、对照试验。
IF 2 4区 医学 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2025-01-01 Epub Date: 2024-08-26 DOI: 10.1159/000541095
Hyonjee Yoon, Jung Hyun Park, Jisu Mun, Youngjae Yoon, Jin-Ju Lee, Minji Ko, Hyun-Hee Cho, Jeong Namkung

Objective: The objective of this randomized controlled trial was to compare the effect of bowel preparation using only oral polyethylene glycol electrolyte (PEG) solution versus oral PEG solution combined with mechanical sodium phosphate (NaP) enema on the surgical field visualization in patients undergoing robot-assisted laparoscopic gynecologic procedures.

Methods: Participants were randomized to either a single oral PEG solution or an oral PEG solution combined by mechanical NaP enema. The intraoperative visualization of the surgical field, the ease of manipulation of the bowels, and overall difficulty level of the surgery were evaluated by the surgeon using a self-administered questionnaire. After the surgery, the patients completed a survey assessing postoperative gastrointestinal discomfort.

Results: A total of 114 women were enrolled and randomized to oral PEG solution-only group (n = 48), and oral PEG plus mechanical NaP enema group (n = 66). Forty-two women in oral PEG-only group and 59 oral PEG plus NaP enema group completed the study. There was no difference in intraoperative visualization or overall difficulty of the operation between the two groups, and bowel manipulation was easier in the oral PEG-only group. Also, there was no difference in operating time between the groups. The patients' level of gastrointestinal discomfort after the surgery was not significantly different between the two groups.

Conclusion: Routine use of mechanical NaP enema before robot-assisted laparoscopic gynecologic surgery is not recommended, because it has no additional benefit regarding intraoperative visualization or the surgical level of difficulty over oral bowel preparation methods.

试验目的这项随机对照试验的目的是比较仅口服聚乙二醇电解质(PEG)溶液与口服聚乙二醇电解质溶液(PEG)联合机械磷酸钠(NaP)灌肠对接受机器人辅助腹腔镜妇科手术的患者手术视野的影响:方法:参与者被随机分配到单一口服PEG溶液或口服PEG溶液联合机械NaP灌肠。外科医生使用自制问卷对术中手术视野的可视性、肠道操作的难易程度以及手术的整体难度进行评估。术后,患者填写了一份评估术后胃肠道不适的调查表:114 名妇女入选并随机分为仅口服 PEG 溶液组(48 人)和口服 PEG 加机械 NaP 灌肠组(66 人)。仅口服 PEG 组 42 名妇女和口服 PEG 加 NaP 灌肠组 59 名妇女完成了研究。两组在术中可视化或整体手术难度方面没有差异,仅口服 PEG 组的肠道操作更容易。此外,两组的手术时间也没有差异。两组患者术后胃肠道不适程度无明显差异:结论:不建议在机器人辅助腹腔镜妇科手术前常规使用机械NaP灌肠,因为与口服肠道准备方法相比,机械NaP灌肠在术中可视化或手术难度方面没有额外的益处。
{"title":"Effectiveness of Mechanical Bowel Preparation before Robot-Assisted Laparoscopic Gynecologic Surgery: A Randomized, Single-Blind, Controlled Trial.","authors":"Hyonjee Yoon, Jung Hyun Park, Jisu Mun, Youngjae Yoon, Jin-Ju Lee, Minji Ko, Hyun-Hee Cho, Jeong Namkung","doi":"10.1159/000541095","DOIUrl":"10.1159/000541095","url":null,"abstract":"<p><strong>Objective: </strong>The objective of this randomized controlled trial was to compare the effect of bowel preparation using only oral polyethylene glycol electrolyte (PEG) solution versus oral PEG solution combined with mechanical sodium phosphate (NaP) enema on the surgical field visualization in patients undergoing robot-assisted laparoscopic gynecologic procedures.</p><p><strong>Methods: </strong>Participants were randomized to either a single oral PEG solution or an oral PEG solution combined by mechanical NaP enema. The intraoperative visualization of the surgical field, the ease of manipulation of the bowels, and overall difficulty level of the surgery were evaluated by the surgeon using a self-administered questionnaire. After the surgery, the patients completed a survey assessing postoperative gastrointestinal discomfort.</p><p><strong>Results: </strong>A total of 114 women were enrolled and randomized to oral PEG solution-only group (n = 48), and oral PEG plus mechanical NaP enema group (n = 66). Forty-two women in oral PEG-only group and 59 oral PEG plus NaP enema group completed the study. There was no difference in intraoperative visualization or overall difficulty of the operation between the two groups, and bowel manipulation was easier in the oral PEG-only group. Also, there was no difference in operating time between the groups. The patients' level of gastrointestinal discomfort after the surgery was not significantly different between the two groups.</p><p><strong>Conclusion: </strong>Routine use of mechanical NaP enema before robot-assisted laparoscopic gynecologic surgery is not recommended, because it has no additional benefit regarding intraoperative visualization or the surgical level of difficulty over oral bowel preparation methods.</p>","PeriodicalId":12952,"journal":{"name":"Gynecologic and Obstetric Investigation","volume":" ","pages":"93-99"},"PeriodicalIF":2.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142072635","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Endometriosis, Anxiety, and Atherosclerosis: A Study of Eight Million Young Hospitalized Women in the USA. 子宫内膜异位症、焦虑和动脉粥样硬化:对美国八百万年轻住院妇女的研究。
IF 2 4区 医学 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2025-01-01 Epub Date: 2024-11-01 DOI: 10.1159/000542049
Hormoz Nassiri Kigloo, Eva Suarthana, Tina Montreuil, Togas Tulandi

Objective: In recent years, several studies have proposed an association between endometriosis and various cardiovascular diseases. Our study evaluated the association between endometriosis and atherosclerosis in patients under 35 years of age using a large population database.

Design: This was a cross-sectional retrospective population-based study.

Participants/materials, setting, methods: We used the data of more than eight million hospitalized women under 35 years of age who were registered in one of the hospitals participating in the Healthcare Cost and Utilization Project - National Inpatient Sample (HCUP NIS) during the study period of 2007-2014. The prevalence of endometriosis, atherosclerosis, and related conditions was estimated, and logistic regression model was used to examine the association.

Results: In the period of study of 8,061,754 patients, we noted an upward pattern for the prevalence of atherosclerosis and a downward trend for endometriosis. Adjusting the analysis for sociodemographic characteristics and comorbidities, the probability of being diagnosed with atherosclerosis was 42% higher in patients with endometriosis (odds ratio [OR] = 1.421; 95% confidence interval [CI]: 1.058-1.910); 35% higher in patients with anxiety (OR = 1.352; 95% CI: 1.249-1.464); and three times higher in women with both endometriosis and anxiety (OR = 3.075; 95% CI: 1.969-4.803) compared to women without those conditions.

Limitations: In HCUP NIS databases, some information such as the severity of disease, laboratory findings, or medical treatment is not available.

Conclusion: The strong association between endometriosis and atherosclerosis suggests that they may share a similar mechanism possibly endothelial dysfunction related to chronic inflammation. Further studies on the potential role of psychological conditions, such as anxiety, on systemic inflammatory diseases are also deemed timely and important.

目的:近年来,一些研究提出了子宫内膜异位症与各种心血管疾病之间的关系。我们的研究利用大型人口数据库评估了 35 岁以下患者的子宫内膜异位症与动脉粥样硬化之间的关系:这是一项基于人群的回顾性研究:我们使用了2007年至2014年期间在参与医疗成本与利用项目--全国住院病人样本(HCUP NIS)的医院中登记的800多万名35岁以下住院妇女的数据。我们估算了子宫内膜异位症、动脉粥样硬化及相关疾病的患病率,并使用逻辑回归模型研究了两者之间的关联:结果:在研究期间,我们发现动脉粥样硬化的患病率呈上升趋势,而子宫内膜异位症的患病率呈下降趋势。在对社会人口学特征和合并症进行调整分析后,子宫内膜异位症患者被诊断为动脉粥样硬化的概率比没有这些疾病的女性高出42%(OR=1.421;95%CI 1.058-1.910);焦虑症患者高出35%(OR=1.352;95%CI 1.249-1.464);同时患有子宫内膜异位症和焦虑症的女性比没有这些疾病的女性高出3倍(OR=3.075;95%CI 1.969-4.803):局限性:HCUP NIS 数据库中没有提供疾病严重程度、实验室检查结果或治疗方法等信息:子宫内膜异位症与动脉粥样硬化之间的密切联系表明,它们可能具有类似的机制,即可能与慢性炎症有关的内皮功能障碍。关于焦虑等心理状况对全身性炎症性疾病的潜在作用的进一步研究也被认为是及时和重要的。
{"title":"Endometriosis, Anxiety, and Atherosclerosis: A Study of Eight Million Young Hospitalized Women in the USA.","authors":"Hormoz Nassiri Kigloo, Eva Suarthana, Tina Montreuil, Togas Tulandi","doi":"10.1159/000542049","DOIUrl":"10.1159/000542049","url":null,"abstract":"<p><strong>Objective: </strong>In recent years, several studies have proposed an association between endometriosis and various cardiovascular diseases. Our study evaluated the association between endometriosis and atherosclerosis in patients under 35 years of age using a large population database.</p><p><strong>Design: </strong>This was a cross-sectional retrospective population-based study.</p><p><strong>Participants/materials, setting, methods: </strong>We used the data of more than eight million hospitalized women under 35 years of age who were registered in one of the hospitals participating in the Healthcare Cost and Utilization Project - National Inpatient Sample (HCUP NIS) during the study period of 2007-2014. The prevalence of endometriosis, atherosclerosis, and related conditions was estimated, and logistic regression model was used to examine the association.</p><p><strong>Results: </strong>In the period of study of 8,061,754 patients, we noted an upward pattern for the prevalence of atherosclerosis and a downward trend for endometriosis. Adjusting the analysis for sociodemographic characteristics and comorbidities, the probability of being diagnosed with atherosclerosis was 42% higher in patients with endometriosis (odds ratio [OR] = 1.421; 95% confidence interval [CI]: 1.058-1.910); 35% higher in patients with anxiety (OR = 1.352; 95% CI: 1.249-1.464); and three times higher in women with both endometriosis and anxiety (OR = 3.075; 95% CI: 1.969-4.803) compared to women without those conditions.</p><p><strong>Limitations: </strong>In HCUP NIS databases, some information such as the severity of disease, laboratory findings, or medical treatment is not available.</p><p><strong>Conclusion: </strong>The strong association between endometriosis and atherosclerosis suggests that they may share a similar mechanism possibly endothelial dysfunction related to chronic inflammation. Further studies on the potential role of psychological conditions, such as anxiety, on systemic inflammatory diseases are also deemed timely and important.</p>","PeriodicalId":12952,"journal":{"name":"Gynecologic and Obstetric Investigation","volume":" ","pages":"194-201"},"PeriodicalIF":2.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142576000","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Identification of Potential Diagnostic Biomarkers and Drug Targets for Endometriosis from a Genetic Perspective: A Mendelian Randomization Study. 从遗传学角度识别子宫内膜异位症的潜在诊断生物标志物和药物靶点:一项孟德尔随机研究。
IF 2.3 4区 医学 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2025-01-01 Epub Date: 2025-02-20 DOI: 10.1159/000543707
Wenhui Wang, Yingjia Zhu, Feng Cheng, Linling Zhu, Xinyun Yang, Mingjie He, Wenhui Wang

Objectives: Endometriosis (EM) is a chronic disease severely impacting reproductive health, with its exact cause still unclear. In-depth understanding of the etiology and pathogenesis of EM from the perspective of genetics and exploring individualized treatment strategies can improve the health and quality of life of patients.

Design: This study combined genetic data analysis with experimental validation to provide novel biomarkers and drug targets for the diagnosis and treatment of EM.

Participants/materials, setting, and methods: Whole blood cis-expression quantitative trait loci (eQTL) data were used as exposure data, and data from the FinnGen database EM1-2 and EM3-4 were used as outcomes. Summary-data-based Mendelian randomization (SMR) methods were used to select genes with causal relationship to the disease. These genes were validated through bioinformatics analysis and real-time quantitative polymerase chain reaction (RT-qPCR) analysis of clinical samples, and potential diagnostic and drug targets were screened through colocalization and molecular docking.

Results: Through SMR analysis, seven genes were selected as potential diagnostic markers of EM, namely Eukaryotic Elongation Factor, Selenocysteine-TRNA-Specific (EEFSEC), INO80 complex subunit E (INO80E), RAP1 GTPase-activating protein (RAP1GAP), Lipid Droplet-Associated Hydrolase (LDAH), Ring Finger And SPRY Domain Containing 1 (RSPRY1), HLA Complex Group 22 (Non-Protein Coding) (HCG22), and Adenosine Kinase (ADK). Colocalization analysis showed that EEFSEC, HCG22, INO80E, and RSPRY1 could be used as potential drug targets.

Limitations: SMR is limited by dependence on publicly available summary data, potential confounding biases in genetic variant-phenotype associations, the presence of underlying horizontal pleiotropy, and issues related to insufficient statistical power. Colocalization analysis cannot assess undiscovered genetic variants. The in vitro experiments in this study utilized clinical samples but were validated only at the expression level. The accuracy of molecular docking analysis largely depends on the quality of protein structures and ligands.

Conclusions: The study identifies potential diagnostic markers and drug targets for EM from a genetic perspective, providing new directions for drug development and precision medicine for EM treatment.

子宫内膜异位症(EM)是一种严重影响生殖健康的慢性疾病,其确切病因尚不清楚。从遗传学角度深入了解EM的病因和发病机制,探索个体化治疗策略,可以改善患者的健康和生活质量。方法:本研究以全血顺式表达定量性状位点(eQTL)数据作为暴露数据,以FinnGen数据库EM1-2和EM3-4数据作为结局。采用基于汇总数据的孟德尔随机化(SMR)方法选择与疾病有因果关系的基因。通过临床样本的生物信息学分析和实时定量聚合酶链反应(RT-qPCR)分析对这些基因进行验证,通过共定位和分子对接筛选潜在的诊断靶点和药物靶点。结果:通过SMR分析,选择真核延伸因子、硒代半胱氨酸- trna特异性(EEFSEC)、INO80复合物亚基E (INO80E)、RAP1 GTPase激活蛋白(RAP1GAP)、脂滴相关水解酶(LDAH)、Ring Finger And SPRY Domain Containing 1 (RSPRY1)、HLA复合物第22组(非蛋白编码)(HCG22)和腺苷激酶(ADK) 7个基因作为EM的潜在诊断标记。共定位分析表明,EEFSEC、HCG22、INO80E和RSPRY1可作为潜在的药物靶点。结论:本研究从遗传学角度确定了EM潜在的诊断标志物和药物靶点,为EM治疗的药物开发和精准医疗提供了新的方向。
{"title":"Identification of Potential Diagnostic Biomarkers and Drug Targets for Endometriosis from a Genetic Perspective: A Mendelian Randomization Study.","authors":"Wenhui Wang, Yingjia Zhu, Feng Cheng, Linling Zhu, Xinyun Yang, Mingjie He, Wenhui Wang","doi":"10.1159/000543707","DOIUrl":"10.1159/000543707","url":null,"abstract":"<p><strong>Objectives: </strong>Endometriosis (EM) is a chronic disease severely impacting reproductive health, with its exact cause still unclear. In-depth understanding of the etiology and pathogenesis of EM from the perspective of genetics and exploring individualized treatment strategies can improve the health and quality of life of patients.</p><p><strong>Design: </strong>This study combined genetic data analysis with experimental validation to provide novel biomarkers and drug targets for the diagnosis and treatment of EM.</p><p><strong>Participants/materials, setting, and methods: </strong>Whole blood cis-expression quantitative trait loci (eQTL) data were used as exposure data, and data from the FinnGen database EM1-2 and EM3-4 were used as outcomes. Summary-data-based Mendelian randomization (SMR) methods were used to select genes with causal relationship to the disease. These genes were validated through bioinformatics analysis and real-time quantitative polymerase chain reaction (RT-qPCR) analysis of clinical samples, and potential diagnostic and drug targets were screened through colocalization and molecular docking.</p><p><strong>Results: </strong>Through SMR analysis, seven genes were selected as potential diagnostic markers of EM, namely Eukaryotic Elongation Factor, Selenocysteine-TRNA-Specific (EEFSEC), INO80 complex subunit E (INO80E), RAP1 GTPase-activating protein (RAP1GAP), Lipid Droplet-Associated Hydrolase (LDAH), Ring Finger And SPRY Domain Containing 1 (RSPRY1), HLA Complex Group 22 (Non-Protein Coding) (HCG22), and Adenosine Kinase (ADK). Colocalization analysis showed that EEFSEC, HCG22, INO80E, and RSPRY1 could be used as potential drug targets.</p><p><strong>Limitations: </strong>SMR is limited by dependence on publicly available summary data, potential confounding biases in genetic variant-phenotype associations, the presence of underlying horizontal pleiotropy, and issues related to insufficient statistical power. Colocalization analysis cannot assess undiscovered genetic variants. The in vitro experiments in this study utilized clinical samples but were validated only at the expression level. The accuracy of molecular docking analysis largely depends on the quality of protein structures and ligands.</p><p><strong>Conclusions: </strong>The study identifies potential diagnostic markers and drug targets for EM from a genetic perspective, providing new directions for drug development and precision medicine for EM treatment.</p>","PeriodicalId":12952,"journal":{"name":"Gynecologic and Obstetric Investigation","volume":" ","pages":"462-482"},"PeriodicalIF":2.3,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12500265/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143467852","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Role of Artificial Intelligence in Gynecologic Oncology Decision-Making: A Feasibility Study. 人工智能在妇科肿瘤决策中的作用:可行性研究。
IF 2.3 4区 医学 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2025-01-01 Epub Date: 2025-02-20 DOI: 10.1159/000544751
Iason Psilopatis, Iason Psilopatis, Nadezda Sipulina, Frederik A Stuebs, Felix Heindl, Patrik Poeschke, Simon Bader, Annika Krueckel, Peter A Fasching, Matthias W Beckmann, Julius Emons

Objectives: The objective of this study was to examine the potential of artificial intelligence (AI) in gynecologic oncology decision-making.

Design: A feasibility study was conducted.

Participants: Fictitious case vignettes of patients with gynecologic carcinomas were used.

Setting: The setting was a fictive one.

Methods: Fictitious case vignettes of gynecologic carcinomas were created and evaluated by physicians with varying levels of professional experience, as well as by language models including ChatGPT 4.0, Google Gemini, and Bing Copilot. Treatment approval decisions were based on standardized clinical and laboratory criteria.

Results: Two cases of breast cancer, 1 case of ovarian cancer, 1 case of cervical cancer, and 1 case of endometrial cancer were evaluated. All three language models were able to evaluate all clinical cases and make therapy-relevant suggestions, with ChatGPT providing the most clear and concise recommendations that were in 3 cases totally consistent with physician assessments.

Limitations: This study was limited to a feasibility study based on five fictitious case vignettes.

Conclusions: The study demonstrates that AI models, such as ChatGPT, can to some extent evaluate clinical cases, recognize clinical and/or laboratory abnormalities, and make therapy-related suggestions. Despite high overall agreement, differences were predominantly noted in the more complex cases, rendering human interpretation necessary. The findings underscore the benefits of AI in terms of clarity, time efficiency, and cost-effectiveness. Future research should further explore the application of AI to real patient data and development of hybrid decision models to optimize integration into clinical practice.

目的:探讨人工智能(AI)在妇科肿瘤决策中的应用潜力。设计:可行性研究。设置:虚构的。参与者:虚构的妇科癌病例。方法:由具有不同专业经验水平的医生,以及Chat-GPT 4.0、谷歌Gemini和Bing-Copilot等语言模型,创建并评估妇科癌的虚构病例。治疗批准决定是基于标准化的临床和实验室标准。结果:对2例乳腺癌、1例卵巢癌、1例宫颈癌和1例子宫内膜癌进行了评估。所有三种语言模型都能够评估所有临床病例并提出与治疗相关的建议,其中Chat-GPT提供了最清晰、最简洁的建议,在三个病例中,这些建议与医生的评估完全一致。结论:本研究表明,Chat-GPT等人工智能模型可以在一定程度上评估临床病例,识别临床和/或实验室异常,并提出治疗相关建议。尽管总体上的一致性很高,但在更复杂的情况下主要注意到差异,因此需要人工解释。研究结果强调了人工智能在清晰度、时间效率和成本效益方面的好处。未来的研究应进一步探索人工智能在真实患者数据中的应用,开发混合决策模型,优化与临床实践的融合。局限性:可行性研究与五个虚构的案例插图。
{"title":"The Role of Artificial Intelligence in Gynecologic Oncology Decision-Making: A Feasibility Study.","authors":"Iason Psilopatis, Iason Psilopatis, Nadezda Sipulina, Frederik A Stuebs, Felix Heindl, Patrik Poeschke, Simon Bader, Annika Krueckel, Peter A Fasching, Matthias W Beckmann, Julius Emons","doi":"10.1159/000544751","DOIUrl":"10.1159/000544751","url":null,"abstract":"<p><strong>Objectives: </strong>The objective of this study was to examine the potential of artificial intelligence (AI) in gynecologic oncology decision-making.</p><p><strong>Design: </strong>A feasibility study was conducted.</p><p><strong>Participants: </strong>Fictitious case vignettes of patients with gynecologic carcinomas were used.</p><p><strong>Setting: </strong>The setting was a fictive one.</p><p><strong>Methods: </strong>Fictitious case vignettes of gynecologic carcinomas were created and evaluated by physicians with varying levels of professional experience, as well as by language models including ChatGPT 4.0, Google Gemini, and Bing Copilot. Treatment approval decisions were based on standardized clinical and laboratory criteria.</p><p><strong>Results: </strong>Two cases of breast cancer, 1 case of ovarian cancer, 1 case of cervical cancer, and 1 case of endometrial cancer were evaluated. All three language models were able to evaluate all clinical cases and make therapy-relevant suggestions, with ChatGPT providing the most clear and concise recommendations that were in 3 cases totally consistent with physician assessments.</p><p><strong>Limitations: </strong>This study was limited to a feasibility study based on five fictitious case vignettes.</p><p><strong>Conclusions: </strong>The study demonstrates that AI models, such as ChatGPT, can to some extent evaluate clinical cases, recognize clinical and/or laboratory abnormalities, and make therapy-related suggestions. Despite high overall agreement, differences were predominantly noted in the more complex cases, rendering human interpretation necessary. The findings underscore the benefits of AI in terms of clarity, time efficiency, and cost-effectiveness. Future research should further explore the application of AI to real patient data and development of hybrid decision models to optimize integration into clinical practice.</p>","PeriodicalId":12952,"journal":{"name":"Gynecologic and Obstetric Investigation","volume":" ","pages":"483-491"},"PeriodicalIF":2.3,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12500289/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143467854","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact on Global Health Status, Quality-Sexual Life and Chronic Fatigue State of Risk-Reducing Salpingo-Oophorectomy in Women Who Are BRCA1/2 Mutation Carriers: Experience from a Third-Level Italian Center. BRCA1/2突变携带者行输卵管卵巢切除术对全球健康状况、性生活质量和慢性疲劳状态的影响:来自意大利三级中心的经验
IF 2.3 4区 医学 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2025-01-01 Epub Date: 2025-02-03 DOI: 10.1159/000543869
Luigi Della Corte, Mario Palumbo, Mario Ascione, Giuseppe D'Angelo, Marco La Verde, Federico Ferrari, Ilaria Morra, Giuseppe Bifulco

Objective: BRCA 1 and 2 mutation carriers are invited to follow intensive clinical and instrumental surveillance programs or are offered prophylactic ovarian surgery. These recommendations impact many aspects of their lives. The primary objective of this study was to assess the overall quality of life (HRQoL) before and after prophylactic bilateral salpingo-oophorectomy (BSO). Secondary objectives were investigating sexual health (SH) and fatigue severity state.

Design: This was a single-center retrospective observational study.

Setting: Women who underwent surgical treatment of bilateral salpingo-oophorectomy between 2018 and 2024 at "DAI Materno Infantile" of Azienda Ospedaliera Universitaria "Federico II" of Naples were included.

Methods: These patients were tracked down to undergo specific questionnaires, such as "Global Health Status (GHS) and Quality of Life Scale (QOL) (EORTC QLQ-C30)," "EORTC Sexual Health Questionnaire (QLQ-SH22)," and "Fatigue Severity Scale (FSS)," to evaluate their psychological, sexual, and general physical condition impact before the surgery, 3 and 6 months later.

Results: The overall mean QoL score was 88.3 ± 29.8 (mean ± standard deviation), and this score worsened when the surgery was performed at 3 months (p < 0.0001) with a score of 51.7 ± 30.7 and a mean difference (MD) of 36.6 points; instead, at 6 months, the overall mean QoL score was 73.1 ± 24.3 with an MD of 21.4 points. FSS reported a score of 2.7 ± 1.15 vs 4.2 ± 1.59 (p < 0.0001) vs 3.5 ± 1.43 (p < 0.0001), respectively, before and 3-6 months after surgery. EORTC QLQ-SH22 before and after treatment showed statistically significant changes in sexual satisfaction (p < 0.0001).

Conclusion: BSO may impact the quality of life regardless of the hormonal status of patients related to age or menopause, about both the functional evaluation and the psychological and emotional assessment report. The physical change related to the surgical procedure is associated with a mental shift that affects both the physical and sexual energy of our patients in the first 3 months postoperatively, with a slight improvement of these data at 6 months.

目的:邀请brca1和2突变携带者进行强化临床和仪器监测计划或提供预防性卵巢手术。这些建议影响了他们生活的许多方面。本研究的主要目的是评估预防性双侧输卵管-卵巢切除术(BSO)前后的总体生活质量(HRQoL)。次要目的是调查性健康(SH)和疲劳严重程度状态(FSS)。设计:这是一项单中心、回顾性观察性研究。背景:纳入2018年至2024年在那不勒斯“费德里科二世”大学“DAI母婴”医院接受双侧输卵管卵巢切除术手术治疗的女性。方法:采用《全球健康状况与生活质量量表(QOL) (EORTC QLQ-C30)》、《EORTC性健康问卷(QLQ-SH22)》、《疲劳程度量表(FSS)》等问卷对患者进行追踪调查,评估术前、术后3个月和6个月的心理、性和一般身体状况的影响。结果:患者总体平均生活质量评分为88.3±29.8分(平均值+标准差),术后3个月该评分进一步恶化(p)。结论:无论与年龄或绝经相关的患者激素状况如何,无论是功能评估还是心理情绪评估报告,BSO均可能影响患者的生活质量。与手术相关的生理变化与术后前3个月影响患者生理量和性能量的心理变化有关,6个月时这些数据略有改善。
{"title":"Impact on Global Health Status, Quality-Sexual Life and Chronic Fatigue State of Risk-Reducing Salpingo-Oophorectomy in Women Who Are BRCA1/2 Mutation Carriers: Experience from a Third-Level Italian Center.","authors":"Luigi Della Corte, Mario Palumbo, Mario Ascione, Giuseppe D'Angelo, Marco La Verde, Federico Ferrari, Ilaria Morra, Giuseppe Bifulco","doi":"10.1159/000543869","DOIUrl":"10.1159/000543869","url":null,"abstract":"<p><strong>Objective: </strong>BRCA 1 and 2 mutation carriers are invited to follow intensive clinical and instrumental surveillance programs or are offered prophylactic ovarian surgery. These recommendations impact many aspects of their lives. The primary objective of this study was to assess the overall quality of life (HRQoL) before and after prophylactic bilateral salpingo-oophorectomy (BSO). Secondary objectives were investigating sexual health (SH) and fatigue severity state.</p><p><strong>Design: </strong>This was a single-center retrospective observational study.</p><p><strong>Setting: </strong>Women who underwent surgical treatment of bilateral salpingo-oophorectomy between 2018 and 2024 at \"DAI Materno Infantile\" of Azienda Ospedaliera Universitaria \"Federico II\" of Naples were included.</p><p><strong>Methods: </strong>These patients were tracked down to undergo specific questionnaires, such as \"Global Health Status (GHS) and Quality of Life Scale (QOL) (EORTC QLQ-C30),\" \"EORTC Sexual Health Questionnaire (QLQ-SH22),\" and \"Fatigue Severity Scale (FSS),\" to evaluate their psychological, sexual, and general physical condition impact before the surgery, 3 and 6 months later.</p><p><strong>Results: </strong>The overall mean QoL score was 88.3 ± 29.8 (mean ± standard deviation), and this score worsened when the surgery was performed at 3 months (p < 0.0001) with a score of 51.7 ± 30.7 and a mean difference (MD) of 36.6 points; instead, at 6 months, the overall mean QoL score was 73.1 ± 24.3 with an MD of 21.4 points. FSS reported a score of 2.7 ± 1.15 vs 4.2 ± 1.59 (p < 0.0001) vs 3.5 ± 1.43 (p < 0.0001), respectively, before and 3-6 months after surgery. EORTC QLQ-SH22 before and after treatment showed statistically significant changes in sexual satisfaction (p < 0.0001).</p><p><strong>Conclusion: </strong>BSO may impact the quality of life regardless of the hormonal status of patients related to age or menopause, about both the functional evaluation and the psychological and emotional assessment report. The physical change related to the surgical procedure is associated with a mental shift that affects both the physical and sexual energy of our patients in the first 3 months postoperatively, with a slight improvement of these data at 6 months.</p>","PeriodicalId":12952,"journal":{"name":"Gynecologic and Obstetric Investigation","volume":" ","pages":"409-418"},"PeriodicalIF":2.3,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143122759","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Gynecologic and Obstetric Investigation
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1